MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis

MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis

Bibliographic Details
Main Authors:	Wan, Yan, Wu, Wei, Yin, Zhihua, Guan, Peng, Zhou, Baosen
Format:	Online
Language:	English
Published:	BioMed Central 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3115916/

Similar Items

Correlations between MDM2 gene SNP309 Polymorphism and Susceptibility to Leukemia
by: Ou, Wen-Bin
Published: (2015)

An Updated Meta-Analysis on the Association of MDM2 SNP309 Polymorphism with Colorectal Cancer Risk
by: Qin, Xue, et al.
Published: (2013)

MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
by: Peng, Qiliu, et al.
Published: (2013)

Prognostic Impact of the MDM2SNP309 Allele in Leukemia and Lymphoma
by: Post, Sean M., et al.
Published: (2010)

Rapid Detection of SNP (c.309T>G) in the MDM2 Gene by the Duplex SmartAmp Method
by: Enokida, Yasuaki, et al.
Published: (2013)

MDM2 SNP309 rs2279744 Polymorphism and Gastric Cancer Risk: A Meta-Analysis
by: Ma, Yong, et al.
Published: (2013)

MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN
by: HE, WENWU, et al.
Published: (2012)

AB265. Association between MDM2 SNP309T>G polymorphism and the risk of bladder cancer: new data in Chinese population and an update meta-analysis
by: Xie, Linguo, et al.
Published: (2016)

Association between MDM2 SNP309 T>G polymorphism and the risk of bladder cancer: new data in a Chinese population and an updated meta-analysis
by: Xie, Linguo, et al.
Published: (2015)

Is MDM2 SNP309 Variation a Risk Factor for Head and Neck Carcinoma?: An Updated Meta-Analysis Based on 11,552 Individuals
by: Zhuo, Xianlu, et al.
Published: (2016)

MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk
by: Knappskog, Stian, et al.
Published: (2011)

Homozygous G/G variant of SNP309 in the human MDM2 gene is associated with earlier tumor onset in Caucasian female renal cell carcinoma patients
by: Stoehr, C G, et al.
Published: (2016)

The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma
by: Hedstrom, Gustav, et al.
Published: (2014)

Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukimia
by: Kaderi, Mohd Arifin, et al.
Published: (2010)

Influence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers
by: Copson, Ellen R, et al.
Published: (2006)

Association of MDM2 SNP309 Variation with Lung Cancer Risk: Evidence from 7196 Cases and 8456 Controls
by: Zhuo, Wenlei, et al.
Published: (2012)

Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
by: YONEDA, TOMOKO, et al.
Published: (2013)

MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1
by: Olsson, Hans, et al.
Published: (2013)

Correction: Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
Published: (2015)

Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
by: Hori, Yasuki, et al.
Published: (2015)

Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers
by: Bjørnslett, Merete, et al.
Published: (2012)

The MDM2 309T>G Polymorphism and Ovarian Cancer Risk: A Meta-Analysis of 1534 Cases and 2211 Controls
by: Ma, Ying-Yu, et al.
Published: (2013)

TP53 and MDM2 Gene Polymorphisms, Gene-Gene Interaction, and Hepatocellular Carcinoma Risk: Evidence from an Updated Meta-Analysis
by: Peng, Qiliu, et al.
Published: (2013)

The T309G MDM2 Gene Polymorphism Is a Novel Risk Factor for Proliferative Vitreoretinopathy
by: Pastor-Idoate, Salvador, et al.
Published: (2013)

Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis
by: Cui, Zhigang, et al.
Published: (2012)

Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues
by: Guan, Peng, et al.
Published: (2012)

Glutathione S-transferase gene GSTM1, gene-gene interaction, and gastric cancer susceptibility: evidence from an updated meta-analysis
by: Lao, Xianjun, et al.
Published: (2014)

Association of the MDM2 SNP285 Polymorphism with Cancer Susceptibility: A Meta-Analysis
by: Wang, Ping, et al.
Published: (2016)

Interaction between Polymorphisms in Pre-MiRNA Genes and Cooking Oil Fume Exposure on the Risk of Lung Cancer in Chinese Non-Smoking Female Population
by: Yin, Zhihua, et al.
Published: (2015)

Association of X-Ray Repair Cross-Complementing Group 1 Arg194Trp, Arg399Gln and Arg280His Polymorphisms with Head and Neck Cancer Susceptibility: A Meta-Analysis
by: Wu, Wei, et al.
Published: (2014)

SNP-SNP interactions in breast cancer susceptibility
by: Onay, Venüs Ümmiye, et al.
Published: (2006)

Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death
by: Rosso, Melissa, et al.
Published: (2015)

Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-Analysis
by: Ding, Hui, et al.
Published: (2016)

How Genome-Wide SNP-SNP Interactions Relate to Nasopharyngeal Carcinoma Susceptibility
by: Su, Wen-Hui, et al.
Published: (2013)

The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models
by: Faur, N, et al.
Published: (2009)

Assessing SNP-SNP Interactions among DNA Repair, Modification and Metabolism Related Pathway Genes in Breast Cancer Susceptibility
by: Sapkota, Yadav, et al.
Published: (2013)

Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis
by: Xue, Zhuowei, et al.
Published: (2016)

A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patients
by: Pan, Xiaolin, et al.
Published: (2013)

Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma
by: Enokida, Yasuaki, et al.
Published: (2016)

Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet’s disease: An updated meta-analysis
by: Zhang, Min, et al.
Published: (2013)